Introduction {#sec1-1}
============

Despite substantial improvements in recent decades, global childhood immunization coverage has stalled at \~85%, with coverage remaining far from optimal in several countries, placing numerous children at risk for morbidity and mortality associated with vaccine-preventable diseases.^[@ref1]^ It is estimated close to 20 million infants do not receive routine EPI services.^[@ref1]^ Sub-Saharan Africa (SSA) has consistently had the lowest immunization coverage globally, with lack of knowledge about immunization schedules, weak health systems, low trust in health authorities, concerns about vaccine safety, and limited access to health facilities associated with low coverage in the region.^[@ref2]^ In West Africa, high dropout rates between vaccine doses require strengthening of immunization delivery systems in the region.^[@ref3]^

In addition to routine infant immunizations, vitamin A supplementation (VAS) for children 6-59 months has been a cornerstone of global child survival programs for decades, with more than 80 countries now having national VAS programs in place.^[@ref4],[@ref5]^ In SSA, VAS has mainly been provided during National Immunization Days (NID) and polio Supplemental Immunization Activities.^[@ref6],[@ref7]^ As these involve door-to-door provision of VAS, coverage has generally been high (\> 80%), in contrast to the lower coverage achieved through health facility-based VAS delivery.^[@ref8]^ More recently, semiannual Child Health Days (CHD) have become a key platform for VAS delivery in SSA.^[@ref9]^ However, funding constraints and successful polio eradication efforts are shifting policies and programs away from NID and CHD campaigns towards integrating VAS into routine facility-based immunization services, thereby posing major challenges for sustaining high coverage levels.^[@ref10]^

Since 2010, Helen Keller International (HKI) has been supporting the integration of VAS into routine facility immunization services in several SSA countries. This has involved introducing a 6-month VAS visit between the pentavalent 3 doses administered at 14 weeks and measles vaccine at 9 months of age.^[@ref13]^ This makes VAS available year-round to age-eligible children, in contrast to the episodic nature of CHDs that occur every 4 to 6 months, which may miss infants turning 6 months between campaign rounds.

Mobile phone interventions, including short message service (SMS) appointment reminders, have shown to be effective for improving immunization coverage in low and middle-income countries.^[@ref14]^ In 2012, HKI began supporting the government of Cote d'Ivoire in the use of mobile phone messaging to increase immunization coverage, given that only 40% of children 12 months of age were estimated to be fully vaccinated in the country.^[@ref17]^ A pilot study was conducted in Korhogo district that involved providing SMS reminders to mothers prior to each routine child immunization and newly-introduced VAS visit. The study revealed SMS reminder messages were not effective for increasing facility attendance due to low literacy and/or messages being missed. In July 2014, a second study was implemented in which mothers were given the option to receive either SMS or voice message reminders prior to scheduled visits. We examined the effect of providing these reminder messages to mothers on attendance at five infant immunization and VAS visits in Korhogo district.

Materials and Methods {#sec1-2}
=====================

Study design and sampling methodology {#sec2-1}
-------------------------------------

The study was a randomized controlled trial conducted at 29 health facilities in Korhogo district in the north-central region of Cote d'Ivoire. Mothers (or caretakers) in the intervention group were provided SMS or voice message reminders, based on their preference, prior to each scheduled facility visit and two additional reminders in the event of non-attendance. Mothers in the control group were not provided any reminder messages. The five visits were: pentavalent 1 (DPT+ Hep B + Hib) immunization at 6 weeks, pentavalent 2 at 10 weeks, pentavalent 3 at 14 weeks, VAS at 6 months, and MMR/yellow fever immunizations at 9 months of age delivered at publicsector facilities.

The sample size was based on detecting a 10% difference in coverage between the intervention and control groups, with β = 0.80, α = 0.05, and a 10% inflation factor to account for potential errors at registration (*e.g*., non-eligible participants). Block randomization was used to allocate motherchild pairs to the intervention or control group based on rural, semi-urban, or urban (Korhogo town) health facility location. Randomization was performed using an automated system and randomization schedules were concealed from health facility personnel. In each setting, purposive sampling was used to select health facilities based on sufficient population density and a well-functioning mobile phone network. Of the 29 facilities, 10 were located in rural areas, 12 in semi-urban areas, and 7 in Korhogo town.

Participant recruitment {#sec2-2}
-----------------------

During July 2014 to June 2015, motherchild pairs were recruited at all 29 health facilities at the time of the child's BCG immunization visit, which occurred within five weeks of the child's birth. If the mother was not present, the accompanying caretaker was invited to participate. To be eligible for the study, the mother/caretaker and child had to be residents of Korhogo district and the mother had to have primary access to a functioning mobile phone. Sociodemo - graphic characteristics were collected for each mother-child pair by health facility staff at the time of enrollment. The study was approved by the Cote d'Ivoire National Research Ethics Committee (*Comité national d'éthique et de la recherche*). All mothers/caretakers provided written informed consent for their and the child's participation.

Data collection and analysis {#sec2-3}
----------------------------

At study enrollment, mothers were informed of subsequent dates for their infant's pentavalent 1-3 and MMR/yellow fever doses and VAS visit, which were also recorded on the child's health card that the mother took home. Dates for immunization sessions were arranged according to the EPI schedule^[@ref13]^ and child's date of birth, excluding days when health facilities did not provide routine services (*e.g*., weekends, holidays). Mothers in the intervention group were given the option to receive either an SMS or voice message reminder in their preferred language (French, Senoufo, or Dioula) prior to each scheduled visit. Messages were devised in collaboration with local EPI personnel and informed mothers to take their child for immunization or VAS in two days to protect the child's health. The content of SMS and voice messages was identical.

In the event the child was not brought to the facility on the scheduled date, another reminder was provided to the mother/caretaker three days after the missed appointment. If the child did not present a second time, a final reminder was sent two days before the next scheduled visit, in an attempt to catch the child up on the missed dose. Mothers in the control group were not provided any SMS or voice messages and were instructed to refer to the child's health card for appointment dates, as per the standard of care in Cote d'Ivoire. A mobile web service platform (Ivocarte^R^, Abidjan) was used to register the mother's mobile phone number and child's visit schedule. SMS and voice messages were then automatically generated and transmitted to recipients at designated times. Attendance records for each visit were transmitted directly from facility staff to study personnel via the Ivocarte^R^ platform. The study outcome measure was attendance at each visit and included children who were brought to the health facility on the scheduled appointment date or any other time during the study period. We conducted bivariate analyses and created multivariable logistic regression models to assess differences in visit attendance between the intervention and control group. Model covariates were selected based on a significant (P\<0.05) bivariate result and/or factors associated with compliance. Covariates included maternal age, education, and employment; child age and gender; and health facility setting (rural, semi-urban, or urban). Results are presented as adjusted odds ratios (aOR) and 95% confidence intervals (CI) and all reported P values are 2-sided with a 0.05 significance level. Analyses were conducted using SPSS version 19.0 (Armonk, NY: IBM Corp) software.

Results {#sec1-3}
=======

A total of 1596 mother-child pairs were enrolled in the study: 798 in the intervention group and 798 in the control group. Participant characteristics were similar between the two groups at recruitment ([Table 1](#table001){ref-type="table"}). Approximately half (46.2%; n=736) of all participants were enrolled at health facilities in Korhogo town, 35.0% (n=560) at facilities in semi-urban areas, and 18.8% (n=300) at rural health facilities. The proportion of male and female children was similar in both study groups. The majority (57.8%; n=922) of mothers/caretakers were between 20-29 years of age, 68.0% (n=1090) had no formal education, and 69.7% (n=1112) reported having no formal employment. The percentage of mothers with no formal education was 92.3% (n=679) in rural areas, 77.1% (n=431) in Korhogo town, and 51.8% (n=155) in semiurban localities. In rural areas, 91.0% (n=669) of mothers reported not working outside the home, as compared to 82.0% (n=459) and 51.6% (n=154) in Korhogo town and semi-urban areas, respectively.

Among mothers in the intervention group, 84.6% (n=675) chose to receive a voice message reminder and 15.4% (n=123) opted to receive an SMS (text) message reminder prior to each child visit. Voice messages were preferred by 97.7% (n=293) of mothers in rural areas and 75.0% (n=552) in Korhogo town. Attendance at each visit was significantly higher in the reminder group, as compared to the control group ([Table 2](#table002){ref-type="table"}), with a mean difference of 17.4% and the largest differences occurring at the 6-month VAS (adjusted OR=5.67; 95% CI: 3.48-9.23) and 9-month MMR/yellow fever (adjusted OR=4.52; 95% CI: 2.84-7.20) sessions. Attendance was highest for the pentavalent 1 dose in both the intervention (86.6%; n=691) and control (76.1%; n=607) groups. While attendance decreased in both groups between the pentavalent 1 dose at 6 weeks and MMR/yellow fever immunization at 9 months, a larger overall decline was observed in the control group, with attendance reaching a low of 37.8% at the 9-month visit. More than half (58.3%; n=465) of infants in the reminder group completed all five visits and were, therefore, fully immunized and supplemented with a dose of vitamin A, compared to 35.7% (n=285) in the control group (P\<0.001). In both groups, the percentage of children attending all visits was highest at facilities in semi-urban areas (intervention: 68.6%; control: 52.5%), followed by rural areas (intervention: 60.7%; control: 36.0%), and facilities in Korhogo town (intervention: 43.8%; control: 16.6%). Infants in semi-urban areas were more likely to receive VAS (OR=1.60; 95% CI: 1.17-2.21) and MMR/yellow fever doses (OR=1.55; 95% CI: 1.14-2.12), as compared to children in rural areas ([Table 3](#table003){ref-type="table"}). Infants in Korhogo town were less likely to receive pentavalent 1 (OR = 0.22; 95% CI: 0.14-0.36), pentavalent 2 (OR=0.28; 95% CI: 0.19-0.41), pentavalent 3 (OR=0.37; 95% CI: 0.26-0.52), VAS (OR=0.39; 95% CI: 0.28-0.54), and MMR/yellow fever (OR=0.56; 95% CI: 0.40-0.79), as compared to children in rural areas. There was no significant difference in attendance at any visit based on the type (SMS *vs*. voice) of message provided.

Discussion and Conclusions {#sec1-4}
==========================

In this study, providing mothers with mobile phone reminder messages increased the proportion of children receiving routine immunizations and vitamin A supplementation. Voice or SMS reminder messages prior to scheduled visits resulted in 20% more fully immunized and vitamin A-supplemented children, compared to the control group. As expected, attendance was higher in semi-urban, compared to rural, areas in both groups. However, the fact that 60% of infants in the intervention group attended all five visits in rural areas suggests providing telephone reminders is a feasible and acceptable approach for increasing immunization and VAS compliance in harder-toreach communities. The fact that infants in Korhogo town were least likely to be brought to immunization and VAS sessions may in part be due to mothers' reliance on nannies and other family members for child care, including preventive health services, in urban areas.

The majority of mothers preferred to receive voice reminders rather than SMS messages. This was likely due to a preference for oral communication channels, a lack of familiarity with text messaging (particularly in rural areas), and challenges related to reading and understanding written messages, given that \~70% of mothers had no formal education. Low levels of education and literacy have shown to be barriers to caregiver access to text message-based interventions in SSA.^[@ref18]^ Though we did not assess the literacy level of our study population, the 2011-2012 DHS indicated 46% and 78% of women in urban and rural areas, respectively, are illiterate in Cote d'Ivoire.^[@ref17]^ Therefore, visual images reminding mothers to attend immunization sessions may be a viable alternative to providing text messages in this context. The fact that attendance was similar between male and female children in urban and rural areas is encouraging and suggests gendered decision-making for child immunization and VAS was not apparent in these settings.

The positive impact of reminder messages in our study is likely due to various reasons. Mothers were reminded about appointments that were scheduled well in advance, which they might have otherwise forgotten. Also, receiving the automated messages may have increased trust and confidence in the health system, thereby making mothers more inclined to seek care for their children. Receiving multiple reminder messages may have instilled a greater sense of obligation on the part of mothers to bring their children for immunizations and VAS.

Our findings are consistent with evidence showing mobile reminders have led to improvements in immunization coverage and decreased dropout rates between doses in Sub-Saharan Africa.^[@ref19]^ A trial in Senegal revealed SMS reminder messages to caretakers resulted in \>60% higher VAS coverage at a 6-month facility visit, with twofold higher coverage in rural compared to urban districts.^[@ref20]^ In Nigeria, phone call reminders to mothers two days and one day before scheduled appointments were effective for increasing infant immunization completion, compared to a control group (RR=1.72; 95% CI: 1.50-1.98).^[@ref21]^ Finally, in a study conducted in Zimbabwe, immunization coverage at 6 weeks was 97% for a group receiving SMS reminder messages, compared to 82% in a non-intervention group, and 95% *vs*. 75% at the 14-week visit in the reminder and control group, respectively.^[@ref22]^

In our study, though mobile reminders increased attendance at immunization and VAS sessions, overall compliance was suboptimal. The fact that 25% and 40% of infants in the reminder and control group, respectively, did not complete all five visits is concerning as it means a large percentage of children were not fully immunized and/or protected against the consequences of vitamin A deficiency during the first year of life. This is consistent with immunization trends in Cote d'Ivoire, with the most recent DHS indicating only 35.7% of children who received BCG vaccine were fully immunized at 12 months of age.^[@ref17]^

Despite the provision of reminders, reasons for non-attendance in both urban and rural areas likely included the high cost of transport to the health facility and mothers not having the time to bring the child and or not having listened to or read the messages. Additionally, logistical factors such as change of phone number/SIM card, which commonly occur in such settings, could have affected attendance. Though we recruited women with primary access to a mobile phone, the practice of phone sharing within households was not investigated and could have influenced whether messages reached intended recipients.

Current data indicate global VAS coverage is at a 6-year low, with particularly sharp declines observed in West and Central Africa.^[@ref23]^ In 2016, only 10 SSA countries reported high (≥80%) recommended twodose VAS coverage.^[@ref23],[@ref24]^ Furthermore, a recent study involving 28 SSA countries revealed only 66% of children 12-23 months received at least one VAS dose.^[@ref25]^ In our study, the 65% attendance for VAS at 6 months in the intervention group indicates potential for successfully integrating VAS into facility-based child health services.

A strength of our study was the randomized design with comparable groups at baseline. Health providers were blinded to the randomization scheme, which reduced the likelihood of bias in service delivery and data recording. Also, immunization and VAS data were uploaded to the web server in real-time, which enabled more efficient monitoring of each child's progress. This likely resulted in more complete and accurate data, as compared to self-reported data and child health cards. However, the recruitment of mother-child pairs at the time of the child's BCG vaccination may have resulted in a sample of mothers who were more proactive in health-seeking practices for their children and, consequently, may have introduced some bias into our sample. In addition, as 19 out of the 29 health facilities in this study also participated in the previous pilot intervention, health providers and communities in these areas may have been more sensitized to the importance of immunization and VAS, as compared to the other 10 facilities. As health facilities were purposively selected in areas with a well-functioning mobile phone network, the findings may not be generalizable to areas with poorer network coverage and where access to mobile phones may also be limited.

A reduction in child morbidity and mortality from vaccine-preventable diseases and vitamin A deficiency requires strengthening facility-based immunization and VAS delivery systems. A major barrier to achieving high coverage is the lack of communication between service providers and caregivers regarding the timing of essential facility visits. Findings from our study suggest the use of simple mobile messaging is feasible and effective for improving immunisation and VAS coverage in Cote d'Ivoire. With rapidly-increasing mobile phone penetration in the country, mobile-based interventions should be considered to strengthen child survival programs in Cote d'Ivoire.
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###### 

Participant characteristics at enrollment.

                         Intervention No. (%)   Control No. (%)   Total No. (%)
  ---------------------- ---------------------- ----------------- ---------------
  Area                                                            
      Rural              150 (9.4)              150 (9.4)         300 (18.8)
      Semi-urban         280 (17.5)             280 (17.5)        560 (35.0)
      Korhogo town       368 (23.1)             368 (23.1)        736 (46.2)
  Mother's education                                              
      No education       541 (67.8)             549 (68.8)        1090 (68.0)
      Primary            123 (15.4)             107 (13.4)        230 (14.0)
      Secondary          117 (14.7)             118 (14.8)        235 (15.0)
      Higher             17 (2.1)               24 (3.0)          41 (3.0)
  Mother's language                                               
      Senoufo            460 (58.6)             471 (60.0)        931 (58.3)
      Dioula             230 (29.3)             209 (26.6)        439 (27.5)
      French             55 (7.0)               67 (8.5)          122 (7.6)
      Other              53 (6.8)               51 (6.5)          104 (6.5)
  Mother's occupation                                             
      Unpaid/homemaker   551 (69.0)             561 (70.3)        1112 (69.7)
      Business           165 (20.7)             160 (20.1)        325 (20.4)
      Employed           39 (4.9)               41 (5.1)          80 (5.0)
      Other              43 (5.4)               36 (4.5)          79 (4.9)
  Mother's age (years)                                            
      ≤19                99 (12.4)              79 (9.9)          178 (11.2)
      20-24              210 (26.3)             226 (28.3)        436 (27.3)
      25-29              234 (29.3)             252 (31.6)        486 (30.5)
      30-34              172 (21.6)             173 (21.7)        345 (21.6)
      35-39              68 (8.5)               60 (7.5)          128 (8.0)
      ≥ 40               15 (1.9)               8 (1.0)           23 (1.0)
  Child sex                                                       
      Female             401 (50.3)             391 (49.0)        792 (49.6)
      Male               397 (49.7)             407 (51.0)        804 (50.4)

N=1596 mother-child pairs; P \> 0.05 for all variables (chi-squared test).

###### 

Immunization and vitamin A supplementation visit attendance.

  Facility visit                                             Intervention No. (%)   Control No. (%)   aOR (95% CI)       P value
  ---------------------------------------------------------- ---------------------- ----------------- ------------------ ---------
  Pentavalent 1^[a](#tfn1){ref-type="table-fn"}^ (6 wk)      691 (86.6)             607 (76.1)        2.85 (1.85-4.37)   \<0.001
  Pentavalent 2^[a](#tfn1){ref-type="table-fn"}^ (10 wk)     646 (81.0)             537 (67.3)        2.80 (1.88-4.17)   \<0.001
  Pentavalent 3^[a](#tfn1){ref-type="table-fn"}^ (14 wk)     592 (74.2)             465 (58.3)        2.68 (1.84-3.91)   \<0.001
  Vitamin A (6 mo)                                           516 (64.7)             325 (40.7)        5.67 (3.48-9.23)   \<0.001
  MMR^[b](#tfn2){ref-type="table-fn"}^/yellow fever (9 mo)   484 (60.7)             302 (37.8)        4.52 (2.84-7.20)   \<0.001

CI: confidence interval; aOR: adjusted odds ratio; N=1596 mother-child pairs. Models adjusted for: mother's age, language, occupation, education; child age and gender; facility location (rural, semi-urban, town), type and number of messages provided.

^a^Diphtheria, tetanus, pertussis, hepatitis B, *Haemophilus influenzae* type B.

^b^Measles, mumps, rubella.

###### 

Immunisation and vitamin A supplementation visit attendance according to health facility location.

  Health facility location   Pentavalent 1^[a](#tfn3){ref-type="table-fn"}^   Pentavalent 2^[a](#tfn3){ref-type="table-fn"}^   Pentavalent 3^[a](#tfn3){ref-type="table-fn"}^   Vitamin A          MMR^[b](#tfn4){ref-type="table-fn"}^/yellow fever
  -------------------------- ------------------------------------------------ ------------------------------------------------ ------------------------------------------------ ------------------ ---------------------------------------------------
  Korhogo town               0.22 (0.14-0.36)                                 0.28 (0.19-0.41)                                 0.37 (0.26-0.52)                                 0.39 (0.28-0.54)   0.56 (0.40-0.79)
  Semi-urban                 1.00 (0.60-1.64)                                 1.10 (0.74-1.66)                                 1.41 (0.99-2.00)                                 1.60 (1.17-2.21)   1.55 (1.14-2.12)
  Rural (ref)                Reference                                        Reference                                        Reference                                        Reference          Reference

CI: confidence interval; OR: odds ratio; Reference group = rural location.

^a^Diphtheria, tetanus, pertussis, hepatitis B, *Haemophilus influenzae* type B.

^b^Measles, mumps, rubella.
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